Actively Recruiting

Phase Not Applicable
Age: 16Years +
All Genders
NCT05207943

Efficacy of the NXSignal Device for the Treatment of Anterior Cruciate Ligament Injuries

Led by University of Las Palmas de Gran Canaria · Updated on 2025-08-28

40

Participants Needed

1

Research Sites

239 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Injury to the anterior cruciate ligament (ACL) is very common among sports professionals and the general population \[. Unlike other joint injuries, it is reversible, but it can damage adjacent tissues, particularly the meniscus, and catalyze knee osteoarthritis. ACL injury produces instability, joint mechanical alteration, which can lead to degenerative joint diseases. The goal of treating the injury will be to prevent symptomatic instability, restore normal knee kinematics, and prevent degenerative joint disease . Its usual treatment is surgical and therefore contributes to a significant cost for the health system, both for the surgeries themselves, and for the rehabilitation and subsequent recovery processes. Within recovery therapies, in some cases, and given their popularity within the world of physiotherapy, electrotherapy techniques are proposed, primarily transcutaneous electrical nerve stimulation-type techniques with action on the muscular system and analgesia. An early intervention with neuromuscular electrostimulation electrotherapy (NMES) combined with repeated exercises is effective for the recovery of strength and restoration of the biomechanical symmetry of the limb. There is a diversity of opinions and disparate results regarding the use of this type of technique , in any case, it has been shown that electrical stimulation favors cell migration and joint tissue regeneration.

CONDITIONS

Official Title

Efficacy of the NXSignal Device for the Treatment of Anterior Cruciate Ligament Injuries

Who Can Participate

Age: 16Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Over 16 years old
  • Mentally competent and in normal condition to participate
  • No previous knee surgeries
  • Able to complete study questionnaires
Not Eligible

You will not qualify if you...

  • Presence of contraindications for treatment with NESA XSIGNAL4, including pacemakers, internal bleeding, poor skin condition, ulcerations or wounds, acute fever, thrombophlebitis, or electricity phobia
  • Not having signed informed consent
  • Urgent surgical interventions

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Las Palmas de Gran Canaria

Las Palmas de Gran Canaria, Las Palmas, Spain, 35016

Actively Recruiting

Loading map...

Research Team

A

Aníbal Báez Suárez, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here